UCeed-funded company Fluid Biotech develops world’s first bio-absorbable flow-diverting stent
Author
Share this article The Fluid Biotech stent is inserted in the blood vessel where the brain aneurysm has developed. Fluid Biotech.
A UCeed-funded medical device company founded by two University of Calgary researchers is developing groundbreaking technology to improve the lives of patients with brain aneurysms.
About five per cent of people harbour a brain aneurysm that, if it bursts, can cause devastating neurological effects and be fatal in one-third of cases.
Focused on revolutionizing the treatment of vascular disease, Fluid Biotech has developed the world’s first bio-absorbable, flow-diverting stent, made almost entirely from a material that is naturally absorbed into the body after the stent has done its job. Traditional vascular stents are mesh tubes that are permanently implanted in the blood vessel and are made completely from metal.